FILE PHOTO: A general view of the Federal University of Sao Paulo (Unifesp) building where the trials of the Oxford/AstraZeneca coronavirus vaccine are conducted, in Sao Paulo, Brazil, June 24, 2020. Picture taken with a drone. REUTERS/Amanda Perobelli
BRASILIA (Reuters) - Clinical trials for the coronavirus vaccine being developed by AstraZeneca PLC and Oxford University resumed in Brazil on Monday after the country's health regulator got confirmation over the weekend that its British equivalent MHRA had approved the restart, a company representative said.
The Federal University of Sao Paulo, which is running the trials, said in a statement that 4,600 of the planned 5,000 volunteers have been vaccinated in Brazil without any of them reporting any serious health issues.
Limited time offer:
Just RM5 per month.
